Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Journal of endocrinological investigation·2002
Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
Thyroid : official journal of the American Thyroid Association·2001
CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
Journal of immunology (Baltimore, Md. : 1950)·2000
A contract research organization perspective on secondary pharmacology: current practices, panel selection, and emerging needs for interpretation.
Journal of pharmacological and toxicological methods·2026
Pharmaceutical registration, essential medicines, and registration depth in Sri Lanka: a longitudinal analysis, 1991-2025.
Journal of pharmaceutical policy and practice·2026
[THE PHARMACEUTICAL HUMANITIES IN RUSSIA AND FOR RUSSIA].
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026
[The Role of Pharmaceutical Universities in Strengthening Japan's Drug Discovery Capabilities: A Pharmaceutical Industry Perspective].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026